SHANGHAI, March 3, 2025 – WuXi AppTec has completed the sale of its U.S. medical device testing operations to NAMSA, a Toledo, Ohio-based testing, clinical and regulatory consulting firm, which was announced on January 17, 2025. All other WuXi AppTec operations are unchanged.